Archives
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2025-09
- 2025-03
- 2025-02
- 2025-01
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-07
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
- 2021-12
- 2021-11
- 2021-10
- 2021-09
- 2021-08
- 2021-07
- 2021-06
- 2021-05
- 2021-04
- 2021-03
- 2021-02
- 2021-01
- 2020-12
- 2020-11
- 2020-10
- 2020-09
- 2020-08
- 2020-07
- 2020-06
- 2020-05
- 2020-04
- 2020-03
- 2020-02
- 2020-01
- 2019-12
- 2019-11
- 2019-10
- 2019-09
- 2019-08
- 2019-07
- 2019-06
- 2019-05
- 2019-04
- 2018-11
- 2018-10
- 2018-07
-
Erastin: Benchmark Ferroptosis Inducer for Cancer Biology...
2026-02-17
Erastin is a validated ferroptosis inducer that selectively triggers iron-dependent, non-apoptotic cell death in RAS/BRAF-mutant tumor cells. Its precise mechanism and reproducibility make it a foundational tool in ferroptosis and oxidative stress research.
-
Chlorpromazine HCl: Dopamine Receptor Antagonist and Clat...
2026-02-17
Chlorpromazine HCl is a phenothiazine antipsychotic and well-characterized dopamine receptor antagonist, extensively used in psychotic disorder research and neuropharmacology studies. This article details its mechanism, experimental benchmarks, and utility as a tool for probing dopamine signaling and endocytic pathways in cell and animal models.
-
Chlorpromazine HCl: Transforming Dopamine Antagonist Rese...
2026-02-16
Chlorpromazine HCl bridges neuropharmacology and cell biology, offering unrivaled versatility for both dopamine receptor antagonism and endocytic pathway interrogation. APExBIO’s rigorously validated product empowers researchers to model psychotic disorders, inhibit clathrin-mediated endocytosis, and troubleshoot complex experimental workflows with precision.
-
Chlorpromazine HCl: Dopamine Antagonist for Neuropharmaco...
2026-02-16
Chlorpromazine HCl is a phenothiazine antipsychotic and potent dopamine receptor antagonist, critical for psychotic disorder research and mechanistic neuropharmacology studies. Its unique dual action on dopamine and GABAA receptors, together with benchmarked roles in endocytic pathway inhibition, makes it a versatile tool for experimental workflows.
-
Optimizing Cell Assays with Benzyl-activated Streptavidin...
2026-02-15
This article provides biomedical researchers with scenario-driven guidance on overcoming common assay and workflow challenges using Benzyl-activated Streptavidin Magnetic Beads (SKU: K1301). Grounded in peer-reviewed data and practical laboratory experience, it details how SKU K1301 enhances reproducibility and efficiency in biotinylated molecule capture, immunoprecipitation, and cell viability assays.
-
Benzyl-activated Streptavidin Magnetic Beads: High-Effici...
2026-02-14
Benzyl-activated Streptavidin Magnetic Beads (SKU: K1301) offer robust, high-specificity purification of biotinylated molecules, streamlining workflows for protein and nucleic acid research. Featuring a hydrophobic, BSA-blocked surface and low nonspecific binding, these beads set a benchmark for immunoprecipitation and interaction studies.
-
Beyond Inhibition: Strategic Protease Modulation for Tran...
2026-02-13
This thought-leadership article explores how the DiscoveryProbe™ Protease Inhibitor Library from APExBIO is redefining the boundaries of translational research by enabling advanced mechanistic dissection and strategic application of protease modulation in high throughput and high content screening. Integrating recent breakthrough findings in cancer biology, competitive benchmarks, and workflow best practices, we provide actionable insights for translational researchers seeking to drive impact in apoptosis, cancer, and infectious disease research.
-
Nilotinib (AMN-107): Precision BCR-ABL Inhibitor Workflows
2026-02-13
Nilotinib (AMN-107) stands out as a selective tyrosine kinase inhibitor, enabling high-fidelity dissection of BCR-ABL and KIT signaling in cancer research. With robust solubility and consistent inhibition across wild-type and mutant kinases, it streamlines experimental workflows while elevating reproducibility in CML and GIST models.
-
Nilotinib (AMN-107): Precision BCR-ABL Inhibition in Stre...
2026-02-12
Discover how Nilotinib (AMN-107), a selective BCR-ABL inhibitor, enables advanced research on tyrosine kinase signaling and ribotoxic stress pathways. This in-depth article uniquely explores Nilotinib’s role in dissecting kinase-driven tumor responses and its implications for stress-activated MAPK signaling.
-
Practical Solutions with EZ Cap™ Human PTEN mRNA (ψUTP): ...
2026-02-12
This article provides evidence-based guidance for deploying EZ Cap™ Human PTEN mRNA (ψUTP) (SKU R1026) in cancer research and functional genomics assays. Drawing on peer-reviewed literature and real laboratory scenarios, it demonstrates how this pseudouridine-modified, Cap1-structured mRNA enables reproducible PI3K/Akt pathway inhibition, robust cell-based data, and workflow efficiency.
-
Abiraterone Acetate in Translational Prostate Cancer Rese...
2026-02-11
This in-depth article explores the strategic deployment of abiraterone acetate—a potent, irreversible CYP17 inhibitor and 3β-acetate prodrug of abiraterone—in the evolving landscape of prostate cancer research. We examine the biological rationale for androgen biosynthesis inhibition, critically assess recent advances in patient-derived 3D spheroid models, and offer translational guidance for leveraging abiraterone acetate (SKU A8202, APExBIO) to bridge the preclinical-clinical divide. By integrating mechanistic insight, competitive context, and evidence from key organoid studies, this article charts a visionary path for next-generation prostate cancer therapeutics and model systems.
-
Optimizing Cell-Based Assays with DiscoveryProbe™ Proteas...
2026-02-11
This scenario-driven guide addresses reproducibility, assay sensitivity, and data interpretation challenges encountered in cell viability and cytotoxicity workflows. By integrating best practices and peer-reviewed findings, we show how the DiscoveryProbe™ Protease Inhibitor Library (SKU L1035) empowers biomedical researchers to achieve robust, high-throughput screening results in apoptosis, cancer, and infectious disease research.
-
Resolving Assay Variability with Benzyl-activated Strepta...
2026-02-10
This article addresses persistent laboratory challenges in cell-based and molecular assays, elucidating how Benzyl-activated Streptavidin Magnetic Beads (SKU: K1301) deliver reproducible, efficient, and high-specificity biotinylated molecule capture. Drawing on workflow scenarios and quantitative context, researchers gain actionable insights into the superior performance and reliability of SKU K1301 for protein and nucleic acid purification, immunoprecipitation, and cell separation.
-
Abiraterone Acetate: Potent CYP17 Inhibitor for Prostate ...
2026-02-10
Abiraterone acetate is a 3β-acetate prodrug of abiraterone, serving as a potent and selective CYP17 inhibitor for castration-resistant prostate cancer (CRPC) research. This article presents atomic, verifiable facts on its mechanism, efficacy benchmarks, and integration into advanced androgen biosynthesis assay workflows.
-
Caspase-3 Fluorometric Assay Kit: Precision Apoptosis & C...
2026-02-09
The Caspase-3 Fluorometric Assay Kit enables sensitive, DEVD-dependent caspase activity detection for apoptosis research. This robust assay platform quantifies caspase-3 activity with high specificity, supporting reproducible workflows in cancer and neurodegeneration studies.